Walter Ricciardi in Verona: “A pandemic treaty is needed…”
The well-known Professor of Hygiene and Public Health at the Università Cattolica del Sacro Cuore in Rome read the future at “Innovabiomed”
Innovabiomed”, two days of training and networking dedicated to innovation in the biomedical sector in which Italy has the first district in Europe and the second in the world: twenty meetings and over one hundred speakers with forty exhibiting companies.
“A global pandemic treaty is needed, an agreement between all the countries of the world and Italy will take an active part to promote it. Countries now must continue to manage this emergency, because we are not out of it yet, and at the same time look to the future. Unfortunately, this Delta variant is very contagious and therefore we must manage it, we must avoid an increase in cases and we can do this by accelerating the vaccination campaign and behaving well in terms of safety measures, but then we must prepare for the future. Today the future provides us with incredible innovations”.
Innovation and the healthcare sector meet in Verona
This was stated today by Walter Ricciardi, Professor of Hygiene and Public Health at the Faculty of Medicine of the Catholic University of the Sacred Heart in Rome, Scientific Advisor to the Minister of Health for the coronavirus pandemic during the inaugural conference of “Innovabiomed”, the two-day event dedicated to networking for the biomedical sector scheduled until tomorrow 3 July at Veronafiere with 20 meetings, over 100 speakers and 40 exhibitors where researchers, device manufacturers, doctors and professionals meet to connect different skills and disciplines, useful for the development of a sector made in Italy leader in Europe and second in the world with 4. 300 companies and 16.5 billion euros of turnover, in which technological progress contributes significantly to improving the quality of life of people.
At “Innovabiomed” the heart valve that will change healthcare
“Innovations that affect prevention, such as vaccines, but also diagnosis, treatment, and rehabilitation,” Walter Ricciardi continued.
“The problem is that these innovations cost money and are also often difficult to manage, because it is not that immediately you change, doctors must learn and health workers must get used to it. So there is also a need for prudent management, that is, a managerial ability to finance innovations and then introduce them. I have to say that the institutions are doing their job, the European ones first of all, because they have made available a quantity of financial resources for the next seven years never seen before in the world: the Horizon Europe program, the highest funding there has ever been. But member states must also do their part and Italy must organize itself better”.
Video, the presentation of “Innovabiomed” 2021 in Verona
Luigi Bertinato: “It is necessary to simplify the tenders.”
And to Walter Ricciardi, during the inaugural conference with the emblematic theme “The Health Care (R)evolution: “Innovabiomed” 2018-2021. Where we were, where we are going and what the Covid-19 emergency taught us”, was echoed by Luigi Bertinato, coordinator of the Clinical Governance Structure and Head of the Scientific Secretariat of the Presidency of the Istituto Superiore di Sanità.
“The pandemic has taught everyone the importance of health and especially the importance of research: in the face of a new disease there has been an explosion of scientific work to bring therapeutic and vaccine solutions for all sectors of society. Public health has been put at the center of civil society and I believe that the same civil society has understood the need for a good health organization. “Innovabiomed wants to take the lessons learned from society, from research, from innovation, from the clinic and make them available so that the future is better than what this year and a half pandemic has been. The technology we need is largely already in place, however, it is necessary to simplify the tenders and encourage the technological reconversion of hospitals. The excellence developed in the Biomedical District, our Silicon Valley of biomedicine, must be made available to the healthcare system more quickly. Health, science and industry must work together. And we need to be connected: between hospital and territory, between robotics and home automation, between healthcare companies, state and other states, between earth and space, between public and private.”
“Innovabiomed”: 20 happening, 100 relatori, tanto networking
Massimiliano Boggetti: “A system with the patient at the center”
A thought shared by Massimiliano Boggetti, President of Confindustria Dispositivi Medici, partner of “Innovabiomed”, who highlighted during his speech as “It is now clear to all that European funds represent a unique opportunity to rethink the NHS, make it modern, sustainable, able to innovate and bring tangible benefits to patients. The effort must be to build a system that puts the patient at the center, moving along some fundamental lines for the revitalization of the health system: invest in a modernization of the hospital technology park, implement territorial medicine and home care, introduce a new system of procurement. But also return to fund basic research, encourage technology transfer and at the same time cultivate a virtuous relationship between doctors and industry.
Alberto Nicolini: “The city of Pico is always up to the task”
And again: “On the choices to be made to achieve these objectives, however, it is necessary to say clearly that the road is uphill and there are many difficulties that PNRR investments could encounter. We ask ourselves therefore”, continued Massimiliano Boggetti, “with which system of procurement the technological park will be modernized because if it is made from an only central purchase the risk is to massificate the question and to aim to the lower price. If the objective is to bring the latest technology to hospitals, it would be necessary to imagine a decentralization, that is, purchases for homogeneous areas that take into account the needs of the territory. Moreover, it would be necessary to define upstream a process of evaluation of innovative technologies, or Health Technology Assessment (HTA), which is serious, independent and funded by the Ministry of Health, in order to acquire the most appropriate devices according to the needs”.
In Verona on July 2-3 there is the biomedical of “Innovabiomed”
Among the authoritative guests the founder Professor Carlo A. Adami
Also attending the inaugural conference were: Maurizio Danese, President of Veronafiere; Federico Sboarina, Mayor of Verona; Manuel Scalzotto, President of the Province of Verona; Manuela Lanzarin, Health Councillor of the Veneto Region; Carlo A. Adami, vascular surgeon, creator of “Innovabiomed” and president of the Scientific Committee of the event; Carlo Calenda, member of the Committee on Industry, Research and Energy of the European Parliament; Mauro Ferrari, CEO BrYet Pharma and professor of Pharmaceutical Sciences at the University of Washington; Gino Gerosa, full professor of Cardiac Surgery at the Faculty of Medicine of the University of Padua, director of the Cardiac Surgery Center and of the Heart Transplantation and Mechanical Assistance Program of the Hospital-University of Padua; Tommaso Ghidini, Head of the Structures, Mechanisms and Materials Division of ESA – European Space Agency; Giampaolo Tortora, Full Professor of Medical Oncology at the Faculty of Medicine of the Università Cattolica del Sacro Cuore in Rome and Director of the Cancer Center and Medical Oncology of the Fondazione Policlinico Universitario Gemelli IRCCS.
“Innovabiomed” is an event organized by Veronafiere in collaboration with distrettobiomedicale.it; it is sponsored by Regione Veneto, Provincia di Verona, Comune di Verona, Università di Verona, Università di Padova, Ordine Nazionale dei Biologi, Federazione Regionale degli Ordini dei Medici Chirururghi e degli Odontoiatri del Veneto. Organizing partner is RPM Media.
“Mirandola’s biomedical? World excellence of Europe”
